Resero partnership boosts data reports for Charles River clients

By Vassia Barba contact

- Last updated on GMT

(Image: Getty/ipopba)
(Image: Getty/ipopba)

Related tags: Charles river laboratories, Charles river, Resero, Research

Charles River Laboratories becomes the exclusive CRO partner for Resero’s nonclinical data report generation tool TurboToxicology.

Charles River Laboratories​ announced the collaboration as part of an investment in Resero Analytics, a developer of data and software solutions for pharmaceutical companies, CROs and regulators.

TurboToxicology, a software tool that analyzes nonclinical data, conducts statistical analyses, applies proprietary algorithms and then formats the data into written reports.

With the use of TurboToxicology, Charles River hopes to accelerate its clients’ access to the reports required for the drug development process before they move on to submissions for Investigational New Drug (IND) or New Drug Approvals (NDA).

“Our goal is to give our clients the gift of time by alleviating some of the upfront administrative work,”​ said Birgit Girshick, corporate executive VP of Discovery and Safety Assessment, Biologics Testing Solutions at Charles River.

Pam Walker, corporate VP of Data and Report Delivery Services and Business Optimization at Charles River told us that TurboToxicology, “utilizes a proprietary algorithm to determine importance of findings and conduct statistical analyses while providing a user-friendly interface for our scientific staff,” ​Walker noted.

Financial details of the agreement were not disclosed.

Related news

Show more

Related products

show more

Paper vs ePRO Data Collection Methods

Paper vs ePRO Data Collection Methods

Signant Health | 19-Oct-2021 | Technical / White Paper

Are you curious why more Sponsors choose digital data collection methods over the traditional pen and paper? Read this recent white paper to discover the...

GLP Tissue Cross Reactivity Testing

GLP Tissue Cross Reactivity Testing

Precision for Medicine | 11-Oct-2021 | Product Brochure

Precision for Medicine's unique combination of research services and tissue procurement capabilities form the pillars of our GLP Tissue Cross Reactivity...

Automating clinical trials for success

Automating clinical trials for success

Formedix | 06-Oct-2021 | Technical / White Paper

This article gives gives a brief overview of why automation is absolutely essential for clinical trial success.

Related suppliers

Follow us

Products

View more

Webinars